Astrana Health
ASTH
13 hedge funds and large institutions have $8.64M invested in Astrana Health in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
615% more capital invested
Capital invested by funds: $1.21M → $8.64M (+$7.43M)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
117% more funds holding
Funds holding: 6 → 13 (+7)
1.34% more ownership
Funds ownership: 0.14% → 1.48% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$6.25M |
| 2 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$1.21M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$838K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$540K |
| 5 |
Morgan Stanley
New York
|
+$329K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$8.49K |
ASTH Hedge Fund Activity: Q1 2018 in Review
13 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q1 2018, worth a combined $8.64M — up 615% from $1.21M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ASTH positions and 0 closed out — a net gain of 7 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, adding an estimated $6.25M. The largest seller was Bank of America, cutting an estimated $8.49K.
- 13 institutional investors held Astrana Health (ASTH) as of Q1 2018, up from 6 in Q4 2017.
- Funds reported $8.64M of Astrana Health stock for Q1 2018, up 615% quarter-over-quarter.
- 7 funds opened new Astrana Health positions in Q1 2018 and 0 closed out, a net change of +7 holders.
- The largest Astrana Health buyer in Q1 2018 was Millennium Management, an estimated $6.25M added.
- The largest Astrana Health seller in Q1 2018 was Bank of America, an estimated $8.49K sold.
Based on aggregated 13F filings for Q1 2018.